This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Potter, P. M. Articles by Danks, M. K. Search for Related Content PubMed PubMed Citation Articles by Potter, P. M. Articles by Danks, M. K.

Isolation and Partial Characterization of a cDNA Encoding a Rabbit Liver Carboxylesterase That Activates the Prodrug Irinotecan (CPT-11)¹

Department of Molecular Pharmacology [P. M. P., C. A. P., C. L. M., M. K. D.], and Center for Biotechnology [C. W. N.], St. Jude Children's Research Hospital, Memphis, Tennessee 38105

We have isolated a cDNA encoding a rabbit carboxylesterase (CE; EC 3.1.1.1) that converts the camptothecin-derived prodrug irinotecan (CPT-11) to the potent topoisomerase I inhibitor 7-ethyl-10-hydroxycamptothecin. NH₂-terminal amino acid sequencing of a purified rabbit CE allowed the design of redundant oligonucleotides to perform PCR from rabbit liver cDNA. DNA sequencing of the PCR product confirmed the identity of the clone, and after both 5' and 3' rapid amplification of cDNA ends, oligonucleotide primers were designed to amplify the entire cDNA. The 1698-bp open reading frame encoded a 565-amino acid protein containing the characteristic CE B-1 and B-2 motifs, a hydrophobic NH₂-terminal leader sequence, and the COOH-terminal residues HIEL that are thought to be responsible for protein localization in the endoplasmic reticulum. Transient expression of the cDNA in COS-7 cells resulted in CE activity in cell extracts and increased the sensitivity of cells to CPT-11. Additionally, stable expression of the rabbit liver CE cDNA in the human glioma U-373 MG cell line resulted in a 56-fold decrease in the IC₅₀ value for CPT-11, whereas the expression of a human alveolar macrophage cDNA encoding a highly homologous CE produced no change in drug sensitivity.

¹ Supported by NIH Grants CA-66124 and CA-63512, Cancer Center Core Grant P30-CA-21765, and the American Lebanese Syrian Associated Charities.

² To whom requests for reprints should be addressed, at Department of Molecular Pharmacology, St. Judge Children's Research Hospital, 332 North Lauderdale Street, Memphis, TN 38105. Phone: (901) 495-3440; Fax: (901) 521-1668; E-mail: phil.potter@stjude.org.

Received 2/ 9/98. Accepted 4/20/98.

This article has been cited by other articles:

				L. M. Wagner, R. E. McLendon, K. J. Yoon, B. D. Weiss, C. A. Billups, and M. K. Danks Targeting Methylguanine-DNA Methyltransferase in the Treatment of Neuroblastoma Clin. Cancer Res., September 15, 2007; 13(18): 5418 - 5425. [Abstract] [Full Text] [PDF]

				K. J. Yoon, J. Qi, J. S. Remack, K. G. Virga, M. J. Hatfield, P. M. Potter, R. E. Lee, and M. K. Danks Development of an etoposide prodrug for dual prodrug-enzyme antitumor therapy. Mol. Cancer Ther., June 1, 2006; 5(6): 1577 - 1584. [Abstract] [Full Text] [PDF]

				M. Alam, D. Gilham, D. E. Vance, and R. Lehner Mutation of F417 but not of L418 or L420 in the lipid binding domain decreases the activity of triacylglycerol hydrolase J. Lipid Res., February 1, 2006; 47(2): 375 - 383. [Abstract] [Full Text] [PDF]

				T. Kubo, S.-R. Kim, K. Sai, Y. Saito, T. Nakajima, K. Matsumoto, H. Saito, K. Shirao, N. Yamamoto, H. Minami, et al. FUNCTIONAL CHARACTERIZATION OF THREE NATURALLY OCCURRING SINGLE NUCLEOTIDE POLYMORPHISMS IN THE CES2 GENE ENCODING CARBOXYLESTERASE 2 (HCE-2) Drug Metab. Dispos., October 1, 2005; 33(10): 1482 - 1487. [Abstract] [Full Text] [PDF]

				E. Tyminski, S. LeRoy, K. Terada, D. M. Finkelstein, J. L. Hyatt, M. K. Danks, P. M. Potter, Y. Saeki, and E. A. Chiocca Brain Tumor Oncolysis with Replication-Conditional Herpes Simplex Virus Type 1 Expressing the Prodrug-Activating Genes, CYP2B1 and Secreted Human Intestinal Carboxylesterase, in Combination with Cyclophosphamide and Irinotecan Cancer Res., August 1, 2005; 65(15): 6850 - 6857. [Abstract] [Full Text] [PDF]

				K. J. P. Yoon, J. L. Hyatt, C. L. Morton, R. E. Lee, P. M. Potter, and M. K. Danks Characterization of inhibitors of specific carboxylesterases: Development of carboxylesterase inhibitors for translational application Mol. Cancer Ther., August 1, 2004; 3(8): 903 - 909. [Abstract] [Full Text] [PDF]

				K. J. P. Yoon, E. J. Krull, C. L. Morton, W. G. Bornmann, R. E. Lee, P. M. Potter, and M. K. Danks Activation of a camptothecin prodrug by specific carboxylesterases as predicted by quantitative structure-activity relationship and molecular docking studies Mol. Cancer Ther., November 1, 2003; 2(11): 1171 - 1181. [Abstract] [Full Text] [PDF]

				H. Stubdal, N. Perin, M. Lemmon, P. Holman, M. Bauzon, P. M. Potter, M. K. Danks, A. Fattaey, T. Dubensky, and L. Johnson A Prodrug Strategy Using ONYX-015-Based Replicating Adenoviruses to Deliver Rabbit Carboxylesterase to Tumor Cells for Conversion of CPT-11 to SN-38 Cancer Res., October 15, 2003; 63(20): 6900 - 6908. [Abstract] [Full Text] [PDF]

				G. Xu, W. Zhang, M. K. Ma, and H. L. McLeod Human Carboxylesterase 2 Is Commonly Expressed in Tumor Tissue and Is Correlated with Activation of Irinotecan Clin. Cancer Res., August 1, 2002; 8(8): 2605 - 2611. [Abstract] [Full Text] [PDF]

				M. M. Meck, M. Wierdl, L. M. Wagner, R. A. Burger, S. M. Guichard, Erik. J. Krull, L. C. Harris, P. M. Potter, and M. K. Danks A Virus-directed Enzyme Prodrug Therapy Approach to Purging Neuroblastoma Cells from Hematopoietic Cells Using Adenovirus Encoding Rabbit Carboxylesterase and CPT-11 Cancer Res., July 1, 2001; 61(13): 5083 - 5089. [Abstract] [Full Text] [PDF]

				R. V. Iyengar, C. A. Pawlik, E. J. Krull, D. A. Phelps, R. A. Burger, L. C. Harris, P. M. Potter, and M. K. Danks Use of a Modified Ornithine Decarboxylase Promoter to Achieve Efficient c-MYC- or N-MYC-regulated Protein Expression Cancer Res., April 1, 2001; 61(7): 3045 - 3052. [Abstract] [Full Text]

				M. K. Danks, C. L. Morton, E. J. Krull, P. J. Cheshire, L. B. Richmond, C. W. Naeve, C. A. Pawlik, P. J. Houghton, and P. M. Potter Comparison of Activation of CPT-11 by Rabbit and Human Carboxylesterases for Use in Enzyme/Prodrug Therapy Clin. Cancer Res., April 1, 1999; 5(4): 917 - 924. [Abstract] [Full Text] [PDF]

				T. J. Wallace, E. M. Kodsi, T. B. Langston, M. R. Gergis, and W. M. Grogan Mutation of Residues 423 (Met/Ile), 444 (Thr/Met), and 506 (Asn/Ser) Confer Cholesteryl Esterase Activity on Rat Lung Carboxylesterase. SER-506 IS REQUIRED FOR ACTIVATION BY cAMP-DEPENDENT PROTEIN KINASE J. Biol. Chem., August 24, 2001; 276(35): 33165 - 33174. [Abstract] [Full Text] [PDF]